Sino Biopharmaceutical reported CNY76.87M in Interest Expense on Debt for its fiscal semester ending in June of 2024.


Interest Expense On Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2023
Avita Medical AUD 1.35M 230K Jun/2024
Cspc Pharmaceutical 10.38M 934K Dec/2024
Dianthus Therapeutics 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 19M 0 Jun/2025
IQVIA Holdings USD 182M 17M Jun/2025
Jiangsu Hengrui CNY 2.25M 2.25M Dec/2024
Moderna USD 1000K 0 Jun/2025
Organon & Co USD 131M 7M Jun/2025
Revvity USD 22.94M 27K Jun/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Tectonic Therapeutic USD 17K 5K Jun/2025
Viatris USD 116.6M 1.1M Jun/2025
Xeris Pharmaceuticals USD 7.36M 343K Jun/2025